Ampliphi Biosciences Corp. | Balance Sheet
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
Cash & Short Term Investments
20,355.00
6,581.00
9,370.00
5,711.00
5,132.00
Total Accounts Receivable
8.00
100.00
125.00
-
-
Other Current Assets
171.00
339.00
521.00
602.00
253.00
Total Current Assets
20,534.00
7,020.00
10,016.00
6,313.00
5,385.00
Net Property, Plant & Equipment
145.00
1,220.00
1,131.00
1,072.00
816.00
Intangible Assets
17,268.00
20,377.00
20,346.00
10,768.00
4,937.00
Total Assets
37,947.00
28,617.00
31,493.00
18,153.00
11,138.00
ST Debt & Current Portion LT Debt
-
-
-
803.00
-
Accounts Payable
2,147.00
1,167.00
-
1,056.00
578.00
Other Current Liabilities
-
701.00
2,385.00
1,679.00
1,390.00
Total Current Liabilities
2,147.00
1,868.00
2,385.00
3,538.00
1,968.00
Long-Term Debt
33,510.00
12,320.00
-
-
-
Deferred Taxes
-
-
3,005.00
2,449.00
1,147.00
Other Liabilities
16,511.00
9,002.00
1,499.00
2,443.00
292.00
Total Liabilities
52,168.00
23,190.00
6,889.00
8,430.00
3,407.00
Common Equity (Total)
14,310.00
3,437.00
12,714.00
9,723.00
7,731.00
Total Shareholders' Equity
14,221.00
5,427.00
24,604.00
9,723.00
7,731.00
Total Equity
14,221.00
5,427.00
24,604.00
9,723.00
7,731.00
Liabilities & Shareholders' Equity
37,947.00
28,617.00
31,493.00
18,153.00
11,138.00
Preferred Stock (Carrying Value)
89.00
1,990.00
11,890.00
-
-
About Ampliphi Biosciences
View Profile
